Suplatast Tosilate Prevents Bleomycin-Induced Pulmonary Fibrosis in Mice

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2009-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1124/jpet.108.141721PMID 18832650
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interferon-γ1b Therapy in Idiopathic Pulmonary Fibrosis: A Metaanalysis

  2005cited by this paper
• Interferon-gamma1b therapy in idiopathic pulmonary fibrosis: a metaanalysis.

  2005cited by this paper
• Feitai, a Chinese herbal medicine, reduces transforming growth factor‐β1 and monocyte chemoattractant protein‐1 expression in bleomycin‐induced lung fibrosis in mice

  2005cited by this paper
• Analyses of efficacy end points in a controlled trial of interferon-gamma1b for idiopathic pulmonary fibrosis.

  2005cited by this paper
• A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis.

  2004cited by this paper
• The role of gp130/IL-6 cytokines in the development of pulmonary fibrosis: critical determinants of disease susceptibility and progression?

  2003cited by this paper
• Effects of suplatast tosilate on cytokine profile of bronchoalveolar cells in allergic inflammation of the lung

  2002cited by this paper
• Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling1

  2001cited by this paper
• American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

  2000cited by this paper
• Effect of Suplatast Tosilate (IPD-1151T) on a Mouse Model of Asthma: Inhibition of Eosinophilic Inflammation and Bronchial Hyperresponsiveness

  2000cited by this paper
• Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1

  2000cited by this paper
• Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement

  2000cited by this paper
• Endogenous MCP-1 influences systemic cytokine balance in a murine model of acute septic peritonitis.

  2000cited by this paper
• Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs.

  1999cited by this paper
• Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases.

  1999cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary fibrosis.

  1997influential reference
• The signal transducer gp130 is shared by interleukin-6 family of haematopoietic and neurotrophic cytokines.

  1997cited by this paper
• Differential CC chemokine-induced enhancement of T helper cell cytokine production.

  1997cited by this paper
• Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease.

  1996cited by this paper
• Costimulation of Fibroblast Collagen and Transforming Growth Factor β1 Gene Expression by Monocyte Chemoattractant Protein-1 via Specific Receptors*

  1996cited by this paper
• A histologically distinctive interstitial pneumonia induced by overexpression of the interleukin 6, transforming growth factor beta 1, or platelet-derived growth factor B gene.

  1995cited by this paper
• Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta.

  1995cited by this paper
• A type 2 (Th2‐like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA)

  1995influential reference
• Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity.

  1994cited by this paper
• Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis.

  1994cited by this paper
• Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis.

  1994influential reference
• Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases.

  1994cited by this paper
• Pharmacokinetic Studies of Suplatast tosilate (IPD-1151 T) (I) :Absorption, Distribution and Excretion after Administration of 14C-Suplatast tosilate (IPD-1151T) to Rats.

  1992cited by this paper
• Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis.

  1992cited by this paper
• Interleukin‐6 in mouse hypersensitivity pneumonitis: changes in lung free cells following depletion of endogenous IL‐6 or direct administration of IL‐6

  1992cited by this paper
• Expression of Ia by murine alveolar macrophages is upregulated during the evolution of a specific immune response in pulmonary parenchyma.

  1988cited by this paper
• The Determination of Hydroxyproline in Tissue and Protein Samples Containing Small Properties of this Acid

  1961cited by this paper
• The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid.

  1961cited by this paper

• Prevention of Renal Interstitial Fibrosis by Suplatast in a Mouse Model.

  2023cites this paper
• Interleukin 4: Its Role in Hypertension, Atherosclerosis, Valvular, and Nonvalvular Cardiovascular Diseases

  2020cites this paper
• Suplatast tosilate reduces radiation‐induced lung injury in mice through suppression of oxidative stress

  2019cites this paper
• Product Data Sheet Inhibitors • A gonists • Screening Libraries

  2018cites this paper
• Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals

  2017cites this paper
• Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib

  2015cites this paper
• Dietary Lutein Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice

  2015cites this paper
• Passion fruit peel extract attenuates bleomycin-induced pulmonary fibrosis in mice.

  2014cites this paper
• Pulmonary , gastrointestinal and urogenital pharnacology Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats

  2012cites this paper
• Evaluation of the antifibrotic effect of fenofibrate and rosiglitazone on bleomycin-induced pulmonary fibrosis in rats.

  2012cites this paper
• Short title: BLTR ANTAGONIST INHIBITS PULMONARY FIBROSIS

  2009cites this paper
• Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis

  2009cites this paper